 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 150
|
|
-
Benitec secures further rights to HIV Therapeutic
(30 Apr 2008)
Collaboration with City of Hope in HIV trial
Benitec Limited has secured further intellectual property rights that underpin its HIV/AIDS lymphoma therapeutic currently undergoing clinical trials at City of Hope in Duarte, California. The therapeutic uses RNAi technology covered by ......
-
Vogelbusch optimises important aspect of the bioethanol production from woody raw materials
(28 Mar 2008)
Vogelbusch GmbH, which is based in Vienna (Austria), announced that it has applied for a patent for an efficient fermentation process for the high-yield extraction of bioethanol from materials containing hemicellulose. Working in partnership ......
-
Oncothyreon announces issuance of patent for PX-867
(27 Mar 2008)
Oncothyreon Inc. announced that the U.S. Patent and Trademark office has issued a patent for PX-867, a small molecule compound currently in preclinical development. The newly issued patent, U.S. Patent No. 7,335,679, includes claims covering ......
-
SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
(18 Mar 2008)
SemBioSys Genetics Inc. announced that it has been granted European patent EP0986309(B1) entitled "Uses of Oil Bodies". The patent has been issued to SemBioSys, which has exclusively licensed commercial rights associated with the patent to ......
-
Applied Biosystems Surpasses Industry Milestone in Lowering the Cost of Sequencing Human Genome
(17 Mar 2008)
Project completed for less than $60,000
Applied Biosystems, an Applera Corporation business, announced a significant development in the quest to lower the cost of DNA sequencing. Scientists from the company have sequenced a human genome using its next-generation genetic analysis ......
-
Jivan Awarded US Patent #7,340,349 for Splice Array Analysis
(11 Mar 2008)
Jivan Biologics Inc. has been awarded US Patent #7,340,349, "Method and System for Identifying Splice Variants of a Gene." The issued claims cover mathematical algorithms for determining the expression levels of splice isoforms of a gene in a ......
-
Generex Biotechnology expands its patent portfolio in North & South America
(07 Mar 2008)
Generex Biotechnology Corporation announced that it has received new patents in Canada and Argentina. The Canadian Intellectual Property Office has granted the Company a new patent titled "Mixed Micellar Pharmaceutical Delivery System and ......
-
Cellexus Biosystems reports the Granting of Fundamental Technology UK Patent
(14 Feb 2008)
The Board of Cellexus Biosystems plc announced that the Company has been issued with the British patent GB2433216 covering the core technology for the CellMaker family of disposable bioreactor and fermentor products. Commenting on this ......
-
Innogenetics secures key patent for hepatitis B drug resistance testing
(08 Feb 2008)
Innogenetics announced that the United States Patent Office has granted a key patent for hepatitis B drug resistance testing. This is the first granted US patent covering a critical mutation leading to hepatitis B viral drug resistance. US ......
-
AVONTEC obtains US patent on its drug candidate AVT-01 decoy ODN
(04 Feb 2008)
AVONTEC GmbH announced that the US Patent and Trademark office has granted a patent that protects its lead drug candidate AVT-01 decoy oligonucleotide (AVT-01 decoy ODN). AVONTEC is developing AVT-01 decoy ODN for the treatment of chronic ......
|
|
|
Top